VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$39.55
-0.47 (-1.17%)
As of Sep 21, 10:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
281.59M
Net Income
16.83M
Gross Margin
74.4%
Profit Margin
6.0%
Rev Growth
+18.9%
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 281.59M 236.85M 156.14M 179.63M
Gross Profit 209.56M 176.26M 99.49M 114.46M
Operating Income 11.26M 8.53M 41.33M 44.36M
Net Income 16.83M 12.74M 35.53M 31.27M
Gross Margin 74.4% 74.4% 63.7% 63.7%
Operating Margin 4.0% 3.6% 26.5% 24.7%
Profit Margin 6.0% 5.7% 22.8% 17.4%
Rev Growth +18.9% +18.9% +24.7% +19.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.78M 5.78M 622.73M 660.37M
Total Equity 1.01B 1.01B 997.81M 1.08B
D/E Ratio 0.01 0.01 0.62 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 23.02M 18.40M 44.60M 53.31M
Free Cash Flow 32.60M 24.70M